Skip to main content
. 2022 Apr 28;71(11):2226–2232. doi: 10.1136/gutjnl-2021-325821

Table 2.

Changes in IBS-SSS, quality of life, anxiety, depression and somatic symptoms (PHQ15) after 8, 16 and 24 weeks of treatment

Changes after 8 weeks of treatment
Medication (n=231) Diet (n=222) P value* P value†
IBS-SSS, mean±SD −76.91±7.42 −97.42±7.37 0.02 0.05
IBS-QoL, mean±SD −7.36±12.45 −8.07±11.45 0.48 0.59
Anxiety, mean±SD −0.97±0.19 −1.21±0.18 0.22 0.32
Depression, mean±SD −1.08±0.27 −1.39±0.26 0.17 0.39
Somatisation, mean±SD −1.26±0.23 −1.82±0.23 0.09 0.09
Changes after 16 weeks of treatment
Medication (n=206) Diet (n=203) P value* P value†
IBS-SSS, mean±SD −78.50±8.04 −104.98±7.66 0.005 0.02
IBS-QoL, mean±SD −8.69±14.07 −9.35±12.23 0.29 0.62
Anxiety, mean±SD −1.03±0.20 −1.31±0.18 0.22 0.30
Depression, mean±SD −1.19±0.28 −1.63±0.25 0.25 0.23
PHQ15, mean±SD −1.48±0.24 −1.81±0.22 0.70 0.33
Changes after 24 weeks of treatment
Medication (n=192) Diet (n=196) P value* P value†
IBS-SSS, mean±SD −86.64±7.81 −97.12±8.18 0.12 0.35
IBS-QoL, mean±SD −9.60±14.32 −10.49±12.79 0.27 0.63
Anxiety, mean±SD −1.16±0.21 −1.33±0.19 0.19 0.53
Depression, mean±SD −1.13±0.30 −1.45±0.28 0.22 0.43
PHQ15, mean±SD −1.90±0.29 −1.84±0.24 0.96 0.91

*Based on completers and Mann-Whitney test.

†Based on all available data and mixed models.

IBS-QoL, IBS quality of life; IBS-SSS, IBS Symptom Severity Scale.